Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

By setting the “baseline” level for activity in neural networks, the NMDAR helps maintain stable brain function amidst ...

Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor (NMDAR)—long studied primarily for ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

Therapy provided via telehealth can reduce a person’s risk of suicide, a new study reports.Cognitive behavior thera ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...

Trippy: The Peril and Promise of Medicinal Psychedelics” looks at both the Indigenous use and modern research behind psychoactive substances.

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...